The Fox Chase Chemical Diversity Center Announces it Has Entered Into a Sponsored Research Agreement with Biohaven Pharmaceutical Holding Company, Ltd. Whereby FCCDC Would Perform Certain Research Services to Advance Biohaven Projects in Neurology, Cancer and Pain.
Doylestown, PA. February 23, 2017- FCCDC is pleased to announce that it has entered into a sponsored research agreement with Biohaven Pharmaceutical Holding Company, Ltd. whereby FCCDC would perform certain research services to advance Biohaven projects in neurology, cancer and pain.